New Data Tool a Boost to State Efforts to Address High and Rising Hospital Prices
Commercial Sector Prices
New Data Tool a Boost to State Efforts to Address High and Rising Hospital Prices
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D
Drug Prices
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D
What’s Next for Payment Reform
Provider Payment Incentives
What’s Next for Payment Reform
Q&A
Getting ‘The Pill’ When You Can’t Get to the Doctor
Contraceptive Choice and Access
Getting ‘The Pill’ When You Can’t Get to the Doctor
Video: ‘Less Money in Our Wallets and Deeper in Debt’
Commercial Sector Prices
Video: ‘Less Money in Our Wallets and Deeper in Debt’
Video Series: Health Care Prices
‘We’ve Come So Far’: The No Surprises Act is a Law Worth Defending
Commercial Sector Prices
‘We’ve Come So Far’: The No Surprises Act is a Law Worth Defending
Provider Consolidation and Competition Issues Ripe for Congressional Action
Commercial Sector Prices
Provider Consolidation and Competition Issues Ripe for Congressional Action
The Perils of Choosing a Plan to Cover Both Medicare and Medicaid
Medicare-Medicaid Integration
The Perils of Choosing a Plan to Cover Both Medicare and Medicaid
Georgetown CHIR’s Katie Keith is Taking on Surprise Medical Billing
Commercial Sector Prices
Georgetown CHIR’s Katie Keith is Taking on Surprise Medical Billing
Women’s History Month
Medicare Negotiation Hearing: 3 Key Takeaways
Drug Prices
Medicare Negotiation Hearing: 3 Key Takeaways
Aduhelm Only Latest Drug to Make Case for Reform
Clinical Trials
Aduhelm Only Latest Drug to Make Case for Reform
AV Calls for Changes to Medicare Advantage to Reduce Overpayments
Medicare-Medicaid Integration
AV Calls for Changes to Medicare Advantage to Reduce Overpayments
Oasis in the Contraception Desert: Pharmacist Prescriptions Increase Access to Birth Control
Contraceptive Choice and Access
Oasis in the Contraception Desert: Pharmacist Prescriptions Increase Access to Birth Control
Proposed Rule from CMS Raises the Bar on Integrated Care
Medicare-Medicaid Integration
Proposed Rule from CMS Raises the Bar on Integrated Care
New Poll: Overwhelming Majority of Americans Support New Ban on Surprise Medical Billing
Commercial Sector Prices
New Poll: Overwhelming Majority of Americans Support New Ban on Surprise Medical Billing
A New Generation in the Fight for Fair Drug Prices
Drug Prices
A New Generation in the Fight for Fair Drug Prices
Q&A
Massachusetts Confronts High-Priced Health System
Commercial Sector Prices
Massachusetts Confronts High-Priced Health System
ANALYSIS
4 Takeaways From a Congressional Hearing on Improving Care for People Eligible for Both Medicare and Medicaid
Medicare-Medicaid Integration
4 Takeaways From a Congressional Hearing on Improving Care for People Eligible for Both Medicare and Medicaid
Contraceptive Choice and Access
How Some Health Insurance Companies Are Breaking the Law
Q&A
Investing in Integration: Indiana’s Long-Term Care System Redesign Focuses on Dual-Eligible Populations
Medicare-Medicaid Integration
Investing in Integration: Indiana’s Long-Term Care System Redesign Focuses on Dual-Eligible Populations
A New Way to Begin the End of HIV in the U.S.
Drug Prices
A New Way to Begin the End of HIV in the U.S.
Q&A
5 Things to Watch in Higher Education, Contraceptives, Evidence-Based Policy, Organ Donation, and Democracy in 2022
Contraceptive Choice and Access
5 Things to Watch in Higher Education, Contraceptives, Evidence-Based Policy, Organ Donation, and Democracy in 2022
Look Ahead
Fallout From Controversial Alzheimer's Drug Continues
Clinical Trials
Fallout From Controversial Alzheimer’s Drug Continues
Congress: Pharma's Price Gouging is Purposeful
Drug Prices
Congress: Pharma’s Price Gouging is Purposeful
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
